Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05833932
Suhexiang Pill for Acute Ischemic Stroke: A Registry Study
Sponsor: Dongzhimen Hospital, Beijing
View on ClinicalTrials.gov
Summary
The primary purpose of this study is to investigate the effectiveness and safety of the Suhexiang Pill for patients with acute ischemic stroke in real-world settings.
Official title: Suhexiang Pill for Acute Ischemic Stroke: A Prospective Registry Study of Real-world Data
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2023-06-01
Completion Date
2024-12-31
Last Updated
2024-06-11
Healthy Volunteers
No
Conditions
Interventions
DRUG
Suhexiang Pill
Suhexiang Pill is an approved traditional Chinese patent medicine.
Locations (2)
Dongzhimen Hospital
Beijing, Beijing Municipality, China
Dongzhimen Hospital
Beijing, Beijing Municipality, China